Back to Agenda
Paediatric Policy Initiatives: Globalisation of Paediatric Drug Development Best Practice or Imperialism of Practice?
Session Chair(s)
Christina Bucci-Rechtweg, MD
Global Head, Maternal Health and Pediatric Regulatory Policy, Novartis , United States
Paediatric legislation implementing a system of obligations and rewards has led to a significant increase in paediatric studies. Whilst studies conducted are multinational, regional regulatory objectives may not serve global research needs. This session will utilise a series of cases which highlight the global nature of paediatric drug development.
Speaker(s)
Julia Bielicki
Attending Physician Pediatrics & Pediatric Infectious Diseases,, University Children's Hospital Basel, Switzerland
Panel Discussion
Angelika Joos, MPHARM
Executive Director, Science & Regulatory Policy, MSD, Belgium
Panel Discussion
Frank Van den Ouweland, DrMed, PHD
Free-lance consultant, Switzerland
Panel Discussion
Cesare Spadoni
Founder and Chairman of the Board, aPODD Foundation, United Kingdom
Panel Discussion
Have an account?